% | $
Quotes you view appear here for quick access.

Opko Health, Inc. Message Board

  • adsmith2036 adsmith2036 Sep 6, 2013 8:16 PM Flag


    Now that Prolor is behind us, what do you think will be then next company OPKO acquires? Or do you think that is all for now until 4K Score is launched?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Frost took a very large position in an asset transfer with RXI Pharmaceuticals, All of OPK's RNAi assets were transferred to RXI in the deal. In fact RXI is the first company to have human trials with RNAi compound.

      Too much to go over, been in this stock over two years, looks very promising for their anti scarring drug rxi-109, no present drug available for anti scarring, planned surgeries alone est. $4B market. Beginning 3 Ph2 trials this fall and they are timely due to the nature of skin healing the trials are short timewise.

      Frost's large position here ( coupled with his background in dermatology ), was based in his thinking IMHO, that rxi-109 looks very promising, especially after stellar Ph1 results.

      Worth a good look, changing over to nasdaq from otcqx any day now....good luck All

    • They are already in the process of acquiring a Russian Company.

      • 2 Replies to lilpimpinmf
      • Yes the Russian main guy was at the meeting. Dimitri. No last name. I don't like dealing with Russia but I think PF said the govt was putting in $30 million. I'm half Russian so dont jump on me please. Dimitri is a lawyer who introduced them to a biotech Opko is working with. They are all about preventing transplanted organ rejection if I Heard correctly and then Opko can also distribute their products.

        Sentiment: Hold

      • I'd like to get behind one maybe two traded companies that has potential to be acquired, but the Dr and Opko has investments in so many. I know some like SFES, but NIMU makes sense too. PFSCF.PK just went public a couple months ago with the guidance of LTS, but that is very speculative.

11.19-0.09(-0.80%)Sep 27 4:00 PMEDT